Tudor Investment Corp Et Al lessened its holdings in Relx Plc (NYSE:RELX – Get Rating) by 59.4% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 25,800 shares of the technology company’s stock after selling 37,686 shares during the period. Tudor Investment Corp Et Al’s holdings in Relx were worth $627,000 at the end of the most recent reporting period.
Several other institutional investors have also recently modified their holdings of RELX. CoreCap Advisors LLC acquired a new position in shares of Relx in the second quarter worth $28,000. Allworth Financial LP raised its stake in Relx by 455.3% in the 3rd quarter. Allworth Financial LP now owns 1,455 shares of the technology company’s stock valued at $35,000 after purchasing an additional 1,193 shares during the last quarter. Pinnacle Bancorp Inc. purchased a new position in Relx in the 3rd quarter valued at about $35,000. Penserra Capital Management LLC acquired a new stake in shares of Relx during the 3rd quarter worth about $36,000. Finally, Wipfli Financial Advisors LLC purchased a new stake in shares of Relx during the third quarter worth about $42,000. 3.41% of the stock is currently owned by institutional investors and hedge funds.
Relx Stock Performance
Shares of Relx stock opened at $30.72 on Monday. The company has a current ratio of 0.59, a quick ratio of 0.53 and a debt-to-equity ratio of 1.56. The business’s fifty day moving average price is $29.25 and its 200 day moving average price is $27.51. Relx Plc has a twelve month low of $23.39 and a twelve month high of $32.24.
Relx Increases Dividend
Analyst Ratings Changes
RELX has been the topic of several recent analyst reports. Morgan Stanley reduced their price objective on shares of Relx from GBX 3,020 ($36.44) to GBX 2,950 ($35.60) in a research note on Friday, December 16th. Barclays cut Relx from an “overweight” rating to an “equal weight” rating in a report on Tuesday, January 31st. StockNews.com started coverage on Relx in a research report on Wednesday, November 30th. They set a “hold” rating on the stock. Credit Suisse Group raised their price target on Relx from GBX 2,800 ($33.79) to GBX 2,860 ($34.51) in a research note on Friday, February 17th. Finally, JPMorgan Chase & Co. increased their price objective on shares of Relx from GBX 2,730 ($32.94) to GBX 2,810 ($33.91) in a report on Thursday, January 26th.
Relx Company Profile
RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.
- Get a free copy of the StockNews.com research report on Relx (RELX)
- MarketBeat Week in Review – 2/27 – 3/3
- The 3 Most Upgraded Stocks Are Reversing
- How to Find Blue Chip Dividend Stocks
- Zscaler, Inc Plummets, Is It Time To Buy The Dip?
- What is a Good Dividend Yield? How to Decide
Receive News & Ratings for Relx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Relx and related companies with MarketBeat.com's FREE daily email newsletter.